Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1987
Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine
P G Chiodini, R Cozzi, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride
D Dallabonzana, A Liuzzi, G Oppizzi, et al.
Clinical Neuropharmacology
|
February 1, 1996
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo
E Martignoni, R Horowski, A Liuzzi, et al.
Journal of Endocrinological Investigation
|
September 1, 1990
Resistance to a long-acting somatostatin analog (SMS 201-995) reversed by surgery in acromegaly
R Attanasio, P G Chiodini, A Liuzzi, et al.
Environmental and Molecular Mutagenesis
|
October 6, 2005
A multi-biomarker analysis of DNA damage in automobile painters
A Testa, F Festa, R Ranaldi, et al.
European Journal of Endocrinology
|
January 1, 1995
Persistence of somatostatinergic tone in acromegaly
R Attanasio, R Cozzi, G Oppizzi, et al.
European Journal of Endocrinology
|
December 16, 1998
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?
R Cozzi, R Attanasio, M Barausse, et al.
Journal of Endocrinological Investigation
|
March 10, 2005
Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
R Cozzi, R Attanasio, S Grottoli, et al.
Journal of Endocrinological Investigation
|
September 1, 1990
Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis
P G Chiodini, R Attanasio, A Liuzzi, et al.
Journal of Endocrinological Investigation
|
April 21, 2001
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases
P Cappabianca, S Lodrini, G Felisati, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1987
Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine
P G Chiodini, R Cozzi, D Dallabonzana, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 1, 1986
Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride
D Dallabonzana, A Liuzzi, G Oppizzi, et al.
Clinical Neuropharmacology
|
February 1, 1996
Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo
E Martignoni, R Horowski, A Liuzzi, et al.
Journal of Endocrinological Investigation
|
September 1, 1990
Resistance to a long-acting somatostatin analog (SMS 201-995) reversed by surgery in acromegaly
R Attanasio, P G Chiodini, A Liuzzi, et al.
Environmental and Molecular Mutagenesis
|
October 6, 2005
A multi-biomarker analysis of DNA damage in automobile painters
A Testa, F Festa, R Ranaldi, et al.
European Journal of Endocrinology
|
January 1, 1995
Persistence of somatostatinergic tone in acromegaly
R Attanasio, R Cozzi, G Oppizzi, et al.
European Journal of Endocrinology
|
December 16, 1998
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?
R Cozzi, R Attanasio, M Barausse, et al.
Journal of Endocrinological Investigation
|
March 10, 2005
Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?
R Cozzi, R Attanasio, S Grottoli, et al.
Journal of Endocrinological Investigation
|
September 1, 1990
Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis
P G Chiodini, R Attanasio, A Liuzzi, et al.
Journal of Endocrinological Investigation
|
April 21, 2001
Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases
P Cappabianca, S Lodrini, G Felisati, et al.
Page
of 8